Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.
On his second day in office, President Donald Trump unveiled a joint, private-sector venture to fund billions of dollars in U ...
CEO Sundar Pichai described current trends as "extraordinary," projecting confidence in the company's forward outlook. Wall ...
The move has been met with a mixture of cautious optimism from tech leaders and apprehension from experts concerned about the ...
An initiative from Google’s parent company that rushes the National Guard to climate disasters stands ready to review aerial images from the LA wildfires.
Alphabet ( GOOG 1.63%) ( GOOGL 1.58%) stock got a small lift on Tuesday, rising 2% higher through 10:30 a.m. ET. The move ...
Artificial intelligence (AI) was a market-driving theme last year, with AI stocks helping the S&P 500, the Nasdaq, and the ...
Big tech companies from Alphabet Inc. to Meta Platforms Inc. face a slate of new investor proposals to probe concerns that ...